🇰🇷 Ditropan Xl in South Korea

Ditropan Xl (OXYBUTYNIN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ditropan Xl in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Ditropan Xl approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ditropan Xl in South Korea?

Hisamitsu Pharmaceutical Co., Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.